Page last updated: 2024-08-25

isoalantolactone and Invasiveness, Neoplasm

isoalantolactone has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, L; Feng, L; Jia, X; Liu, D; Song, J; Wang, J; Zhang, Z	1

Other Studies

1 other study(ies) available for isoalantolactone and Invasiveness, Neoplasm

Article	Year
Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-κB signaling pathway. Oncology reports, 2016, Volume: 36, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Sesquiterpenes; Signal Transduction; Transcription Factor RelA	2016

Article

Year

Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-κB signaling pathway.

Oncology reports, 2016, Volume: 36, Issue:3

Topics: Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Sesquiterpenes; Signal Transduction; Transcription Factor RelA

2016